Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
265,957,447
-
Total 13F shares
-
52,992,751
-
Share change
-
+962,004
-
Total reported value
-
$1,158,352,799
-
Put/Call ratio
-
41%
-
Price per share
-
$21.87
-
Number of holders
-
153
-
Value change
-
+$26,029,052
-
Number of buys
-
74
-
Number of sells
-
75
Institutional Holders of Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM) as of Q2 2023
As of 30 Jun 2023,
Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM) was held by
153 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,992,751 shares.
The largest 10 holders included
FMR LLC, JPMORGAN CHASE & CO, VANGUARD GROUP INC, BlackRock Inc., T. Rowe Price Investment Management, Inc., Bellevue Group AG, Champlain Investment Partners, LLC, MILLENNIUM MANAGEMENT LLC, BRAIDWELL LP, and AMERIPRISE FINANCIAL INC.
This page lists
153
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.